Varenicline: A Miracle For Smokers Or Simply Another False Hope?

Smokers have many incentives to quit smoking. The health risk of smoking is bigger today then at any other point in history. It seems that with each passing year more is known about cigarettes and the health problems that stem from them. The problem is not a lack of motivation or incentive on the smoker’s part, but it is quite simply a hard addiction. There have been many stop-smoking aids that have been released in the last 15 years. Some of these include the Nicorette gum and the famous stop-smoking Patch. Recently however, there has been a new stop-smoking aid that has entered the market. Varenicline, sold under the name Chantix, has many people hopeful for a stop-smoking method that actually works.

Chantix was recently approved by the Food and Drug Administration (FDA). It is the first stop-smoking aid to be approved by the FDA in almost 10 years. This has many people excited about the possibility that it may actually work. Although there have been some very positive test results shown with Chantix, it is still currently in the testing phase, and not available to the mass market. More will be known on the effects of Chantix once it is released.

In a nutshell, Chantix works by attaching itself to nicotine receptors in the brain, which is supposed to help prevent cravings. It does not actually contain any nicotine, instead containing Cytisine, which is commonly referred to as “False Tobacco”. This differs from most stop-smoking aids which contain certain amounts of nicotine.

It is difficult to tell at this point whether or not Chantix will become the be-all and end-all of the stop-smoking aid world. Until more is known and more studies have been done, people should use caution before hailing Chantix as a miracle drug. Only you and your doctor can dtermine if you should try this drug.

Get more info on Varenicline and a variety of subjects at Articles for Life.

Article Source: http://www.wellnessarticlelibrary.com

Please Rate this Article

5 out of 54 out of 53 out of 52 out of 51 out of 5 

Not yet Rated